Physician profile
Burt Webb
NPI 1083762421
$4,344.67
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $499 · 2021: $2,223 · 2022: $685 · 2023: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,534.98 | 2021-2022 | |
| Abbvie INC. | $902.32 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Intuitive Surgical, INC. | $489.50 | 2020-2021 | |
| Therapeuticsmd, INC. | $275.31 | 2019-2021 | |
| Hologic Sales and Service, LLC | $206.05 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $196.03 | 2021-2022 | |
| Apyx Medical Corporation | $106.59 | 2019 | |
| Astellas Pharma US INC | $90.08 | 2019-2023 | Veozah |
| Lupin INC. | $81.17 | 2019-2021 | |
| Minerva Surgical, INC | $55.87 | 2019 | |
| Duchesnay USA Incorporated | $48.94 | 2019 | |
| Acerus Pharmaceuticals Corporation | $46.09 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.09 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $34.88 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.52 | 2022-2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $32.22 | 2020 | |
| Coopersurgical, INC. | $22.84 | 2022 | |
| Organon LLC | $19.67 | 2022 | |
| Virtus Pharmaceuticals LLC | $17.56 | 2021 | |
| Millicent US INC | $17.00 | 2023 | Intrarosa, Femring |
| Amag Pharmaceuticals, INC. | $16.39 | 2019 | |
| Avion Pharmaceuticals | $15.99 | 2022 | |
| Merck Sharp & Dohme LLC | $14.65 | 2019 | |
| Azurity Pharmaceuticals, INC. | $13.82 | 2023 | Adthyza |
| Daiichi Sankyo INC. | $13.73 | 2019 | |
| Covidien Lp | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Burt Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.